Filing Details

Accession Number:
0001209191-21-033402
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-18 11:36:39
Reporting Period:
2021-05-17
Accepted Time:
2021-05-18 11:36:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1668243 Urogen Pharma Ltd. URGN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1363812 Molly Henderson C/o Urogen Pharma Ltd.
400 Alexander Park Drive
Princeton NJ 08540
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-05-17 2,500 $15.85 2,500 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct